Granules India Limited has informed the Exchange regarding allotment of 51,28,205 equity shares pursuant to Preferential Issue at its meeting held on February 23, 2026.
GRANULES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts more than Nifty Smallcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Granules India has allotted 2.5 crore convertible warrants to its promoter group (Chigurupati family members) and non-promoter investors at Rs. 585 per warrant. Additionally, 51,28,205 fully paid-up equity shares were allotted to 8 non-promoter investors (mostly 360 ONE funds) at Rs. 585 per share, raising Rs. 300 crores. The promoter group, led by Mrs. Chigurupati Uma Devi, will see her stake rise from 3.81% to 12.51% on a fully diluted basis once all warrants are exercised. The company received Rs. 365.625 crores as 25% upfront payment on warrants, with the balance 75% payable within 18 months upon conversion. Paid-up equity capital increases from Rs. 24.26 crores to Rs. 24.77 crores immediately, and up to Rs. 27.27 crores on a fully diluted basis.
The promoter group's increased stake signals strong insider confidence in the company's future, which is generally viewed positively by retail investors. The fresh equity infusion of Rs. 300 crores plus up to ~Rs. 1,462 crores from warrant conversion will strengthen the balance sheet for growth or expansion. However, potential dilution of up to ~12% on full conversion is a key consideration for existing shareholders.